PAN Yiting, LI Yansong, DING Yinzhang, WANG Kai, XU Di. Progress in diagnosis and treatment of heart failure with preserved ejection fraction[J]. Journal of Clinical Medicine in Practice, 2024, 28(22): 143-148. DOI: 10.7619/jcmp.20242229
Citation: PAN Yiting, LI Yansong, DING Yinzhang, WANG Kai, XU Di. Progress in diagnosis and treatment of heart failure with preserved ejection fraction[J]. Journal of Clinical Medicine in Practice, 2024, 28(22): 143-148. DOI: 10.7619/jcmp.20242229

Progress in diagnosis and treatment of heart failure with preserved ejection fraction

  • Heart failure with preserved ejection fraction (HFpEF) is defined as having a left ventricular ejection fraction (LVEF) of ≥50% accompanied by elevated natriuretic peptide (BNP) levels or other evidence of congestion. HFpEF is characterized by high morbidity and mortality rates and has surpassed heart failure with reduced ejection fraction (HFrEF) to become the predominant form of heart failure. This article reviewed the definition, epidemiology, classification, diagnosis, pathology, comorbidities, and treatment of HFpEF, providing evidence for clinical research.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return